T1	Participants 118 195	Patients with chronic kidney disease, including kidney transplant recipients,
T2	Participants 722 846	Participants are clinically stable renal transplant recipients who are 6 months or longer posttransplant with elevated tHcy.
T3	Participants 1420 1467	2234 of the target 4000 patients were enrolled.